Summary of Significant Accounting Policies - Additional Information (Details) |
12 Months Ended | ||
|---|---|---|---|
|
Dec. 31, 2025
USD ($)
item
shares
|
Dec. 31, 2024
USD ($)
shares
|
Jun. 30, 2026
USD ($)
shares
|
|
| Summary of Significant Accounting Policies | |||
| Accumulated deficit | $ (435,980,000) | $ (380,136,000) | $ (460,668,000) |
| Cash, cash equivalents and marketable securities | $ 41,800,000 | ||
| Number of accredited financial institutions that are federally insured | item | 2 | ||
| Property and Equipment, Net | |||
| Impairment loss recognized | $ 0 | $ 1,200,000 | |
| Preferred Stock | |||
| Preferred stock, shares outstanding | shares | 0 | 0 | 0 |
| Research and Development Costs, Including Clinical Trial Accruals and Acquired in Process Research and Development | |||
| Accrued clinical trial costs | $ 900,000 | ||
| Income Taxes | |||
| Uncertain income tax benefits, interest or penalties | $ 0 | ||
| X | ||||||||||
- Definition Represents the amount of accrued clinical trial expenses. No definition available.
|
| X | ||||||||||
- Definition The amount of cash, cash equivalents and marketable securities. No definition available.
|
| X | ||||||||||
- Definition Represents the number of accredited financial institutions that are federally insured. No definition available.
|
| X | ||||||||||
- Definition Not available. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of accumulated undistributed earnings (deficit). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|